DiscoverBreast Cancer TrialsImproving Treatment Outcomes: Advancing Adjuvant Therapy for Early ER+ Breast Cancer
Improving Treatment Outcomes: Advancing Adjuvant Therapy for Early ER+ Breast Cancer

Improving Treatment Outcomes: Advancing Adjuvant Therapy for Early ER+ Breast Cancer

Update: 2025-01-15
Share

Description

Dr Erica Mayer is the director of clinical research and institute physician at the Breast Oncology Centre, Dana-Faber Cancer Institute, and associate professor of medicine at Harvard Medical School in Boston, United States.

Dr Mayer's research focuses on the role of novel therapies in the treatment of breast cancer and we spoke with her about improving efficacy in the adjuvant treatment of early ER+ breast cancer.

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Improving Treatment Outcomes: Advancing Adjuvant Therapy for Early ER+ Breast Cancer

Improving Treatment Outcomes: Advancing Adjuvant Therapy for Early ER+ Breast Cancer

Breast Cancer Trials